VIEWING ONLY POSTERS| VIEWING ONLY POSTERS| VIEWING ONLY
M Reindl, SJ Reinstadler, HJ Feistritzer, G Klug, J Mair… - academic.oup.com
Conclusion: LR did not offer a prognostic benefit in patients with ischemic cardiomyopathy
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
[PDF][PDF] VIEWING ONLY POSTERS| VIEWING ONLY POSTERS| VIEWING ONLY
M Reindl, SJ Reinstadler, HJ Feistritzer, G Klug, J Mair… - europepmc.org
Conclusion: LR did not offer a prognostic benefit in patients with ischemic cardiomyopathy
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
[PDF][PDF] VIEWING ONLY POSTERS| VIEWING ONLY POSTERS| VIEWING ONLY
M Reindl, SJ Reinstadler, HJ Feistritzer, G Klug, J Mair… - ncbi.nlm.nih.gov
Conclusion: LR did not offer a prognostic benefit in patients with ischemic cardiomyopathy
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
[PDF][PDF] VIEWING ONLY POSTERS| VIEWING ONLY POSTERS| VIEWING ONLY
M Reindl, SJ Reinstadler, HJ Feistritzer, G Klug, J Mair… - scholar.archive.org
Conclusion: LR did not offer a prognostic benefit in patients with ischemic cardiomyopathy
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …
and low EF. Scar burden did not associate with prognosis in either LR or MED group. In the …